+ 100.000
employees around the world
€6 bln
annual investments in R&D by 2020
73
production sites in 32 countries of the world


Key therapeutic areas of the company
- Diabetes & cardiovascular diseases;
- Consumer Healthcare;
- Specialty care (rare diseases, multiple sclerosis, oncology & immunology);
- Vaccines.